Proscia has received a CE Mark for its Concentriq Dx solution for use in primary diagnosis. With this certification, Proscia accelerates its entry into the diagnostic pathology market in Europe and other key geographies globally to help laboratories keep pace with the rising cancer burden. Read more here:
Featured Story:
Latest Articles
December 19, 2024
December 3, 2024